A Russian scientist says he plans to produce genetically modified babies, an act that would make him only the second person known to have done so. It would also run counter to the scientific consensus that such experiments should be banned until an international ethical framework has agreed on the circumstances and security measures that would justify them. Conversely, several concerns have been raised about the possibility of creating custom babies, particularly with regard to the inefficiencies currently created by technologies. Bioethicist Ronald Green explained that while technology is “inevitable in our future,” he predicted “serious mistakes and health problems as unknown genetic side effects in `modified` children. [84] In addition, Green cautioned that “the rich” could have easier access to technology. that make them even better. This concern about germline editing, which exacerbates a societal and financial divide, is shared by other research, with Professor Karen Yeung, president of the Nuffield Bioethics Council, pointing out that if funding the procedures “exacerbated social injustice, we don`t think it would be an ethical approach.” [6] Human genome editing is prohibited by policies, laws and regulations in most countries. However, the first criminal case against genome-modified babies was convicted in China in 2019. In this commentary, we discuss our legal considerations on this case. Genome editing on healthy human embryos can lead to irreversible mutations and serious consequences for the inheritance of future generations, while their long-term safety is unpredictable. A comprehensive set of laws, regulations and guidelines should be formulated to punish genome editing behaviour and prevent similar negative events in the future. More effective and binding mechanisms should be put in place and implemented between different countries. A cooperation network should be strengthened to enable better global registration and monitoring of technologies and research for the processing of the human genome.
Molecular biologist Denis Rebrikov told Nature that he plans to implant genetically modified embryos in women, possibly before the end of the year, if he can get approval by then. Chinese scientist He Jiankui sparked an international outcry when he announced last November that he had made the world`s first genetically modified babies – twins. Some scientists oppose the ban on trying to use genetically modified embryos to make babies. Mark Schiefelbein/AP Hide the legend Human genome editing is largely banned by laws or guidelines, even in countries that allow research on human embryonic stem cells [4]. Many countries have banned human genome editing. Thirty-nine countries were studied and classified as “legislation-based prohibition” (25 countries), “directive-based prohibition” (4), “ambiguous” (9) and “restrictive” (1). China, India, Ireland and Japan prohibit genome editing on the basis of less enforceable guidelines than laws and amendments are subject to [3]. In the United States, human genome editing is not prohibited, but a moratorium is imposed under the vigilance of the guidelines of the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). All clinical trial proposals for germline changes are rejected by the NIH`s Recombinant DNA Advisory Committee (RAC). Clinical trials are regulated by the FDA [5]. In the UK, legislation on the medical use of mitochondrial replacement is likely to lead to legal approval of germline nuclear genome editing, which can be easily modified by genome editing technology [6].
The report does not call for a change in UK legislation to allow genetically modified babies, but rather calls for research into the safety and effectiveness of the approach, its societal impact and a broad debate about its effects. At least two groups of scientists in the United States want to study the procedure that originally led to the ban. This procedure, known as mitochondrial replacement therapy, involves creating embryos with the DNA of three different people, resulting in so-called “three-parent babies.” DNA editing also raises the possibility of “tailor-made babies,” in which the genetic code of embryos created by standard IVF is rewritten so that children have traits that parents deem desirable. The Nuffield report does not exclude specific applications of genome editing, but says that to be ethical, all applications must follow the principles of being in the best interests of the child, and not have a negative impact on society. Many countries have comprehensive bans on the treatment of human embryos, but in other cases, the rules are not as clearly defined. Even if this is the case, these rules are rarely legally binding. They found that 29 countries (red above) had a complete legal ban on genetic processing. One of the reasons genetically modified embryos have sparked a huge global debate is that if the modifications are allowed to become babies, they can be passed on to future generations – a far-reaching procedure known as germline alteration. Researchers agree that the technology could one day help eliminate genetic diseases such as sickle cell disease and cystic fibrosis, but many more tests are needed before they can be used to modify people. A baby designer is a baby whose genetic makeup has been selected or modified, often to capture a specific gene or to suppress genes associated with the disease. [1] This process typically involves the analysis of a wide range of human embryos to identify genes associated with certain diseases and traits and the selection of embryos that have the desired genetic makeup.
A process known as preimplantation genetic diagnosis. Screening for individual genes is commonly performed, and polygenic screening is offered by some companies. [2] Other possible methods that can be used to alter a baby`s genetic information include direct genome editing before birth, which is not done regularly, and there is only one known case of this that has occurred since 2019, when Chinese twins Lulu and Nana were edited as embryos, leading to widespread criticism. [3] Baylis also highlights the potential problem of “ethical dumping” – a practice in which researchers relocate their work to a country without prohibitions or with no or limited ability to enforce these prohibitions. Baylis notes that this has been observed in other areas such as assisted reproductive technologies and unproven stem cell therapies. Many bioethicists point out that germline technology is generally considered to be in the best interest of a child, so the associate must be supported.
